Navigation Links
Lexicon Presents LX4211 Clinical Data at European Association for the Study of Diabetes Annual Meeting
Date:9/13/2011

tic and commercial potential of LX4211. This press release also contains forward-looking statements relating to Lexicon's growth and future operating results, discovery and development of products, strategic alliances and intellectual property, as well as other matters that are not historical facts or information.  All forward-looking statements are based on management's current assumptions and expectations and involve risks, uncertainties and other important factors, specifically including those relating to Lexicon's ability to successfully conduct clinical development of LX4211 and preclinical and clinical development of its other potential drug candidates, advance additional candidates into preclinical and clinical development, obtain necessary regulatory approvals, achieve its operational objectives, obtain patent protection for its discoveries and establish strategic alliances, as well as additional factors relating to manufacturing, intellectual property rights, and the therapeutic or commercial value of its drug candidates, that may cause Lexicon's actual results to be materially different from any future results expressed or implied by such forward-looking statements.  Unless specifically indicated otherwise, results reported as trends were not statistically significant. Information identifying such important factors is contained under "Risk Factors" in Lexicon's annual report on Form 10-K for the year ended December 31, 2010, as filed with the Securities and Exchange Commission.  Lexicon undertakes no obligation to update or revise any such forward-looking statements, whether as a result of new information, future events or otherwise.


'/>"/>
SOURCE Lexicon Pharmaceuticals, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2

Related medicine technology :

1. Lexicon Pharmaceuticals to Present at Morgan Stanley Global Healthcare Conference
2. Lexicon Pharmaceuticals to Present at Stifel Nicolaus Healthcare Conference
3. Lexicon Pharmaceuticals to Present at the Wedbush 2011 Life Sciences Management Access Conference
4. Lexicon Announces Publication of Results From the Phase 2 Trial of LX1031 in Patients With Irritable Bowel Syndrome in Journal of Gastroenterology
5. Phase 2 Trial of Lexicons LX1032, Telotristat Etiprate, Shows Positive Results in Carcinoid Syndrome
6. Lexicon Pharmaceuticals Reports on Clinical Program Status and 2011 Second Quarter Results
7. Lexicons IBS Drug Candidate, LX1033, Successfully Completes Phase 1 Clinical Trial
8. Lexicon Presents LX4211 Mechanism of Action Data at American Diabetes Association Meeting and Announces Commencement of Phase 2b Clinical Trial in Type 2 Diabetes
9. Lexicon Pharmaceuticals Announces Webcast of 2011 Annual R&D Day
10. Lexicon Pharmaceuticals Reports on Clinical Program Status and 2011 First Quarter Results
11. Lexicon to Provide First Quarter 2011 Financial Results
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/22/2014)... , Aug. 22, 2014  WaferGen Bio-systems, Inc. (NASDAQ: ... offering of units of common stock and warrants at ... of $20 million, prior to deducting underwriting discounts and ... shares and warrants are immediately separable and will be ... to begin trading on The NASDAQ Stock Market under ...
(Date:8/21/2014)... Hermann Health System and The University of Texas ... to provide a new level of specialized breast screening at ... Houston area. Starting in ... professional breast radiology services for five of Memorial Hermann,s 10 ... Woodlands , Northeast, Southwest and Sugar Land ...
(Date:8/21/2014)... Nektar Therapeutics (NASDAQ: NKTR ... results from its Phase 3 pivotal clinical trial ... factor VIII (rFVIII) treatment for hemophilia A based ... primary endpoint in reducing annualized bleed rates (ABR) ... arm. Top-line results from the prospective, ...
Breaking Medicine Technology:WaferGen Bio-Systems Announces Pricing of $20 Million Underwritten Offering and Uplisting to NASDAQ 2WaferGen Bio-Systems Announces Pricing of $20 Million Underwritten Offering and Uplisting to NASDAQ 3WaferGen Bio-Systems Announces Pricing of $20 Million Underwritten Offering and Uplisting to NASDAQ 4Memorial Hermann, MD Anderson join forces to provide enhanced breast imaging services throughout the Greater Houston Region 2Memorial Hermann, MD Anderson join forces to provide enhanced breast imaging services throughout the Greater Houston Region 3Memorial Hermann, MD Anderson join forces to provide enhanced breast imaging services throughout the Greater Houston Region 4Baxter Announces Positive Top-Line Results from Its Phase 3 Study of BAX 855, Extended Half-Life Recombinant FVIII for Hemophilia A Patients 2Baxter Announces Positive Top-Line Results from Its Phase 3 Study of BAX 855, Extended Half-Life Recombinant FVIII for Hemophilia A Patients 3Baxter Announces Positive Top-Line Results from Its Phase 3 Study of BAX 855, Extended Half-Life Recombinant FVIII for Hemophilia A Patients 4Baxter Announces Positive Top-Line Results from Its Phase 3 Study of BAX 855, Extended Half-Life Recombinant FVIII for Hemophilia A Patients 5
(Date:8/23/2014)... 2014 Dealing with a drug or alcohol ... the addict is a child. Adolescent addiction has been an ... time, but a new helpline is now providing a valuable ... to find a real addiction recovery center. , The Troubled ... impact in the community. By calling (404) 975-2762, parents and ...
(Date:8/23/2014)... 2014 Teen drug and alcohol abuse ... different in Wilmington, NC. Substance abuse can happen to ... to drug and alcohol dependency in higher numbers than ... overcome substance abuse, but don’t know where to find ... can be a challenge because most treatment options are ...
(Date:8/23/2014)... Summer vacation is almost over and before we know ... shopping for school supplies and a new wardrobe might take ... students to also spend some time brushing up on bed ... thrive in heavily populated places,” said Randy Rupert, Bed Bug ... perfect settings for bed bugs to take up residence.” , ...
(Date:8/22/2014)... The IT manager of Top10BestSEOHosting.com is a ... years. He has recently announced that GoDaddy ( http://www.top10bestseohosting.com/go/GoDaddy.com/ ... 2014. , GoDaddy is a popular supplier of cheap ... hosting solutions at affordable rates. It offers three Linux ... plans depend on the length of the contract. The ...
(Date:8/22/2014)... On Friday, Aug. 22, Liberty University ... Sciences , hosting a ceremony in its courtyard attended ... and public welfare. , The 162-member inaugural class of ... (LUCOM) joined Liberty staff, faculty, and community leaders in ... new medical school. Classes began on Monday, Aug. 4. ...
Breaking Medicine News(10 mins):Health News:Atlanta’s New Troubled Teen Helpline Is Making a Difference in the Community 2Health News:Troubled Teens Wilmington Helpline Guides Adolescents to the Path of Recovery 2Health News:Expert Advice for a Bed Bug-Free School Year 2Health News:Liberty University Dedicates Its New Center for Medical and Health Sciences 2Health News:Liberty University Dedicates Its New Center for Medical and Health Sciences 3Health News:Liberty University Dedicates Its New Center for Medical and Health Sciences 4
... it still hasn,t been determined whether one disorder causes ... (HealthDay News) -- Alcohol abuse may increase the risk ... New Zealand study suggests. , Previous research has identified ... depression. But it hasn,t been determined whether one disorder ...
... Calif., March 6 Huntington Hospital Cancer Center ... the American College of Surgeons Commission on Cancer ... excellence in providing quality care to their patients."This ... commitment by Huntington,s medical staff, hospital staff and ...
... knees less effective in deep joint areas, study finds ... injection of hyaluronic acid is no more effective than a ... finds. , Hyaluronic acid (HA), a substance found in normal ... fluid, which lubricates and protects joints. The use of HA ...
... 6 /PRNewswire-Asia-FirstCall/ -- China Yingxia,International, Inc. (OTC ... a leading provider in the nutraceutical industry ... nutritional food products,dietary supplements and personal care ... today disclosed that its CEO and chairwoman, ...
... chest wall to decrease volume, study says , , FRIDAY, ... middle can put the squeeze on your lungs, according ... , It was already known that abdominal obesity (waist ... than 40 inches for men) was associated with diabetes, ...
... 6 The Penta Water Company ( http://pentawater.com ), ... water, is taking the bold step of turning to ... for their new packaging.In collaboration with Earth First Packaging ... the bottle water industry to convert its plastic-based BOPP ...
Cached Medicine News:Health News:Drinking May Trigger Genetic Marker for Depression 2Health News:Huntington Hospital Cancer Center Receives Outstanding Achievement Designation 2Health News:Hip Osteoarthritis Therapy No Better Than Placebo 2Health News:China Yingxia International, Inc.'s chairwoman and CEO is in talks with investors in China 2Health News:China Yingxia International, Inc.'s chairwoman and CEO is in talks with investors in China 3Health News:Belly Fat Puts the Pressure on Lungs 2Health News:Back to Basics: Penta Water Pairs Its Ultra-Pure Water With Packaging Made of Rock 2
Autolensmeter with color 5.7 inch LCD screen and built in printer....
... CF-60UVi is a diversified wide-angle ... FAG, ICG (optional) with various ... in the market), 40 degrees ... one picture and 30 degrees ...
... to eliminate the subjective nature of manual ... repeatable, objective measurements every time. The easy ... operating system ensure fast and simple operation. ... lens positioning and, in auto mode, users ...
An ideal basic fundus fluorescein camera with quality enhancing features at a mid-range price point. The camera has 1.7x magnification at 60 degree and 2.5x at 40 degree....
Medicine Products: